Angel News

Angel News

Back to Homepage

26th June 2018

Maven backs BioAscent with £1.6 million investment

Maven Capital Partners has completed a £1.6 million investment in BioAscent Discovery Limited, an integrated drug discovery services business. The funding will enable BioAscent to significantly expand its service offering, adding complementary chemistry and biology services and capitalise on the growing trend towards the outsourcing of drug discovery activities. The funding will support the creation of 10 new jobs, including in highly skilled scientific positions, and fund additional laboratory space.


Register now to read full story

In order to read the full story we need you to register with us, please click the link below:

Register Now

Add a comment:




Enter the characters in the image shown:

Back to Homepage